Related Experiment Video

Updated: Jul 14, 2026

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic

Elahe A Mostaghel1, Stephanie T Page, Daniel W Lin

  • 1Fred Hutchinson Cancer Research Center, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.

Cancer Research
|May 19, 2007
PubMed

Insights

Androgen deprivation therapy for prostate cancer does not consistently suppress prostate androgen levels or gene expression. Novel approaches are needed for complete androgen ablation in the prostate microenvironment.

Area of Science:

  • Urology
  • Oncology
  • Molecular Biology

Background:

  • Androgen deprivation therapy (ADT) is a cornerstone treatment for advanced prostate cancer.
  • The efficacy of ADT has not been thoroughly assessed at the tissue and molecular level within the prostate.
  • Understanding androgen suppression in the prostate microenvironment is crucial for optimizing cancer treatment.

Purpose of the Study:

  • To evaluate the efficacy and consistency of medical castration in reducing prostate androgen levels.
  • To assess the impact of ADT on androgen-regulated gene expression in prostate tissue.
  • To investigate the heterogeneity of androgen receptor (AR) and prostate-specific antigen (PSA) expression during ADT.

Main Methods:

  • Analysis of prostate tissue samples from healthy men and prostate cancer patients undergoing short-term and neoadjuvant ADT.
  • Measurement of androgen levels and gene expression using microarray profiling, quantitative reverse transcription-PCR, and immunohistochemistry.
  • Comparison of outcomes between medical castration (using a GnRH antagonist) and placebo.

Main Results:

  • Medical castration reduced prostate tissue androgens by 75% and suppressed some androgen-regulated genes (NDRG1, FKBP5, TMPRSS2).
  • Key genes like AR and PSA were not consistently suppressed, even after 9 months of neoadjuvant ADT.
  • Significant heterogeneity in PSA and AR protein expression was observed in prostate cancer samples during ADT.

Conclusions:

  • Medical castration based on serum testosterone does not guarantee complete androgen ablation in the prostate.
  • Standard ADT lacks consistent suppression of androgen-dependent gene expression, potentially allowing cancer cell survival.
  • Future treatments must target complete suppression of both systemic and intracrine androgen sources for optimal prostate cancer therapy.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Related Concept Videos

Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...